Adverse drug reactions: Managing the risk

Journal of Nursing Management

Volumn 17, Issue 2, 2009, Pages 175-184

  Jordan, Sue ^a   Jones, Richard ^a,b   Sargeant, Matthew P ^b,c  

^a SWANSEA UNIVERSITY   (United Kingdom)

^b HYWEL DDA UNIVERSITY HEALTH BOARD   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Adverse drug reactions; Crisis resolution home treatment; Electronic records; Medication monitoring; Risk management

Indexed keywords

PSYCHOTROPIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE MANAGEMENT; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; HOME CARE; HUMAN; MEDICAL AUDIT; MEDICAL RECORD; MENTAL DISEASE; MIDDLE AGED; MULTICENTER STUDY; NURSING; ORGANIZATION AND MANAGEMENT; PILOT STUDY; UNITED KINGDOM;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; AGED, 80 AND OVER; CASE MANAGEMENT; DRUG MONITORING; GREAT BRITAIN; HOME CARE SERVICES; HUMANS; MEDICAL AUDIT; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MENTAL DISORDERS; MIDDLE AGED; PILOT PROJECTS; PSYCHOTROPIC DRUGS; WALES;

EID: 64549107240     PISSN: 09660429     EISSN: 1365263X     Source Type: Journal    
DOI: 10.1111/j.1365-2834.2009.00977.x     Document Type: Article

References (76)

1. Aronson J.K. (ed 2006) Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions. Elsevier, London.
2. Audit Commission (2001) A Spoonful of Sugar: Medicines Management in NHS Hospitals. Audit Commission, London.
3. Barker P., Keady J., Croom S., Stevenson C., Adams T. Reynolds W. (1998) The concept of serious mental illness: modern myths and grim realities. Journal of Psychiatric and Mental Health Nursing 5, 247 254.
4. Barnes T.R., Paton C., Cavanagh M.R., Hancock E. Taylor D.M., UK Prescribing Observatory for Mental Health (2007) A UK audit of screening for the metabolic side effects of antipsychotics in community patients. Schizophrenia Bulletin 33 (6 1397 1403
5. Barnes T.R., Paton C., Hancock E., Cavanagh M.R., Taylor D. Lelliott P., UK Prescribing Observatory for Mental Health (2008) Screening for the metabolic syndrome in community psychiatric patients prescribed antipsychotics: a quality improvement programme. Acta Psychiatrica Scandinavia 118 (1 26 33.
6. Beecroft N., Becker T., Griffiths G., Leese M., Slade M. Thornicroft G. (2001) Physical health care for people with severe mental illness: the role of the GP. Journal of Mental Health 10 (1 53 61.
7. Brown S. (1997) Excess mortality of Schizophrenia. British Journal of Psychiatry 171, 502 508.
8. Brown M., Brown J. Bayer M. (1987) Changing nursing practice through continuing education in physical assessment: perceived barriers to implementation. The Journal of Continuing Education in Nursing 18, 111 115.
9. Chyka P. (2000) How many deaths occur from adverse drug reactions in the United States? American Journal of Medicine 109, 122 130.
10. Colton C.W. Manderscheid R.W. (2006) Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Preventing Chronic Disease 3 (2 A42 1 14.
11. Committee of Public Accounts (2006) A Safer Place for Patients: Learning to Improve Patient Safety. Committee of Public Accounts, House of Commons, The Stationery Office, London.
12. Correll C.U. (2007) Balancing efficacy and safety in treatment with antipsychotics. CNS Spectrums 12 (10 Suppl. 17 12 20.
13. Curfman G., Morrissey S. Drazen J. (2006) Blueprint for a stronger food and drug administration. New England Journal of Medicine 355 (17 1821.
14. Degner D., Grohmann R., Kropp S. et al. (2004) Severe adverse drug reactions of antidepressants: results of the German multicenter drug surveillance program AMSP. Pharmacopsychiatry 37 (Suppl. 1 S39 S45.
15. DoH (2000) An Organisation with a Memory: Report of an Expert Group on Learning from Adverse Events in the NHS. The Stationery Office, London.
16. DoH (2001) Medicines and Older People: National Service Framework. HMSO, London.
17. DRC (Disability Rights commission) (2007) Equal Treatment: Closing the Gap - One Year on. Report of the Reconvened Formal Inquiry Panel to the DRC's Formal Investigation into the Inequalities in Physical Health Experienced by People with Mental Health Problems and Learning Disabilities [WWW document]. DRC, London. Available at http://www.learningdisabilitiesuk.org.uk/docs/DRCrpt. pdf, accessed on 27 October 2008.
18. Fagiolini A. (2008) Overcoming hurdles to achieving good physical health in patients treated with atypical antipsychotics. European Neuropsychopharmacology 18 (Suppl. 2 S102 S107.
19. French D.D., Campbell R., Spehar A., Cunningham F. Foulis P. (2005) Outpatient medications and hip fractures in the US. Drugs and Aging 22 (10 877 885.
20. Gandhi T., Burstin H., Cook F. et al. (2000) Drug complications in outpatients. Journal of General and Internal Medicine 15, 149 154.
21. Gandhi T., Weingart S., Seger A. et al. (2005) Outpatient prescribing errors and the impact of computerized prescribing. Journal of General and Internal Medicine 20, 837 841.
22. Gladstone J. (1995) Drug Administration errors: a study into the factors underlying the occurrence and reporting of drug errors in a district general hospital. Journal of Advanced Nursing 22 (4 628 637.
23. Griffith R., Griffiths H. Jordan S. (2003) Continuing professional development: administration of medicines. Part 1. The Law Nursing Standard 18 (2 47 54.
24. Grol R. (2001) Improving the quality of medical care. Journal of the American Medical Association 286, 2578 2585.
25. Gurwitz J., Field T., Harrold L. et al. (2003) Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 289, 1107 1116.
26. Hazell L. Shakir S.A. (2006) Under-reporting of adverse drug reactions: a systematic review. Drug Safety 29 (5 385 396.
27. Healthcare Commission (2007) Talking about Medicines: The Management of Medicines in Trusts Providing Mental Health Services. Commission for Healthcare Audit and Inspection, London.
28. Heeley E., Riley J., Layton D., Wilton L. Shakir S. (2001) Prescription-event monitoring and reporting of adverse drug reactions. Lancet 358, 1872 1873.
29. Herxheimer A. Sanz E. (2008) Social, cultural and ethical aspects of drug use - changes over 40 years: a personal look back. European Journal of Clinical Pharmacology 64, 107 114.
30. Holland R., Lenaghan E., Harvey I. et al. (2005) Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial Britsih Medical Journal 330, 293 295.
31. Hoult J 2006) Setting the scene. In Crisis Resolution and Home Treatment. A Practical Guide (P. McGlynn ed.), pp. 11 21. The Sainsbury Centre for Mental Health, London.
32. Howard R., Avery A., Slavenburg S. et al. (2007) Which drugs cause preventable admissions to hospital? A systematic review. British Journal of Clinical Pharmacology 63 (2 136 147.
33. Hu X.H., Bull S.A, Hunkeler E.M. et al. (2004) Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate. Journal of Clinical Psychiatry 65 (7 959 965.
34. International Conference on Harmonisation (ICH) (1996) ICH Harmonised Tripartite Guideline for Good Clinical Practice. Institute of Clinical Research, Marlow.
35. IOM (Institute of Medicine) (2006) The Future of Drug Safety: Action Steps for Congress. National Academies' Press, Washington DC. Available at http://www.iom.edu/CMS/3793/26341/37329.aspx, accessed on 23 October 2008.
36. Jones R. Robinson B 2008) A National Survey of Crisis Resolution Home Treatment Teams in Wales. All Wales Crisis Resolution Home Treatment Network, Cardiff. Available at http://www.wales.nhs.uk/sites3/Documents/776/ ANationalSurveyofCRHTTeamsinWales.pdf, accessed on 23 October 2008.
37. Jordan S. (2002) Managing adverse drug reactions: an orphan task. Developing nurse-administered evaluation checklists. Journal of Advanced Nursing 38, 437 448.
38. Jordan S. (2007) Adverse drug reactions: reducing the burden of treatment. Nursing Standard 21 (34 35 41.
39. Jordan S 2008) The Prescription Drug Guide for Nurses. Open University Press, McGraw-Hill, Maidenhead.
40. Jordan S., Hardy B. Coleman M. (1999) Medication management: an exploratory study into the role of Community Mental Health Nurses. Journal of Advanced Nursing 29, 1068 1081.
41. Jordan S., Tunnicliffe C. Sykes A. (2002) Minimising side effects: the clinical impact of nurse-administered 'side effect' checklists. Journal of Advanced Nursing 37, 155 165.
42. Jordan S., Knight J. Pointon D. (2004) Monitoring adverse drug reactions: scales, profiles and checklists. International Nursing Review 51, 208 221.
43. Jureidini J. Tonkin A. (2006) Overuse of antidepressant drugs for the treatment of depression. CNS Drugs 20 (8 623 632.
44. Lampela P., Hartikainen S., Sulkava R. Huupponen R. (2007) Adverse drug effects in elderly people - a disparity between clinical examination and adverse effects self-reported by the patient. European Journal of Clinical Pharmacology 63 (5 509 515.
45. Lewin K 1948) Resolving Social Conflicts. Harper & Row, New York, NY.
46. Matson J.L., González M.L., Smith K.R., Terlonge C., Thorson R.T. Dixon D.R. (2006) Assessing side effects of pharmacotherapy treatment of bipolar disorder: a 20-year review of the literature. Research in Developmental Disabilities 27 (5 467 500.
47. Medawar C. (1997) The antidepressant web - marketing depression and making medicines work. International Journal of Risk & Safety in Medicine 10 (2 75 126.
48. Medawar C., Reed T. Alves T 2008) Pharmageddon: Health Climate Change? Social Audit Ltd., London. Available at http://www.socialaudit.org.uk/6080326. htm, accessed on 25 October 2008.
49. Morgan S. (2000) Clinical Risk Management. A Clinical Tool and Practitioner Manual. The Sainsbury Centre for Mental Health, London.
50. Munro B.H. (2005) Selected non-parametric techniques. In Statistical Methods for Health Care Research, 5th edn (B. H. Munro ed.), pp. 109 136. Lippincott Williams and Wilkins, Philadelphia, PA.
51. Nash M. (2005) Physical care skills: a training needs analysis of inpatient and community mental health nurses. Mental Health Practice 9 (4 20 23.
52. NICE (National Institute for Clinical Excellence) (2004) Depression: Management of Depression in Primary and Secondary Care. Clinical guideline 23. NICE, London.
53. NPSA (National Patient Safety Agency) (2007) Safety in Doses: Medication Safety Incidents in the NHS. National Patient Safety Agency, London. Available at http://www.npsa.nhs.uk, accessed on 23 October 2008.
54. Olsen S., Neale G. Schwab K. et al (2007) Hospital staff should use more than one method to detect adverse events and potential adverse events: incident reporting, pharmacist surveillance and local real-time record review may all have a place. Quality and Safety in Health Care 16 (1 40 44.
55. Onyett S., Linde K., Glover G., Floyd S., Bradley S. Middleton H 2006) A National Survey of Crisis Resolution Teams in England. Care Services Improvement Partnership, London.
56. Osborn D.P., Levy G., Nazareth I., Petersen I., Islam A. King M.B. (2007) Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Research Database. Archives of General Psychiatry 64 (2 242 249.
57. POMH Prescribing Observatory for Mental Health (2008a) Topic 2c report 2c. Screening for Metabolic Side Effects of Antipsychotic Drugs in Patients Treated by Assertive Outreach Teams: Supplementary Audit. The Royal College of Psychiatrists, College Centre for Quality Improvement, London.
58. POMH Prescribing Observatory for Mental Health (2008b) Topic 6a. Assessment of the Side Effects of Depot Antipsychotics. The Royal College of Psychiatrists, College Centre for Quality Improvement, London.
59. RCP/NICE (Royal College of Psychiatrists, National Institute for Clinical Excellence) (2003) Schizophrenia: Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care. Royal College of Psychiatrists, London.
60. Roethlisberger F.S. Dickson W.J. (1939) Management and the Worker. Harvard University Press, Cambridge, MA.
61. Royal College of General Practitioners (1985) What Sort of Doctor: Assessing Quality of Care in General Practice. Report from General Practice no.23. Royal College of General Practitioners, London.
62. Royal S., Smeaton L., Avery AJ., Hurwitz B. Sheikh A. (2006) Interventions in primary care to reduce medication related adverse events and hospital admissions: systematic review and meta-analysis. Quality and Safety in Health Care 15 (1 23 31.
63. Ryan T. (1998) Perceived risks associated with mental illness: beyond homicide and suicide. Social Science and Medicine 46 (2 287 297.
64. Serretti A. Artioli P. (2004) The pharmacogenomics of selective serotonin reuptake inhibitors. Pharmacogenomics 4 (4 233 244.
65. Smyth MG. Hoult J. (2000) The home treatment enigma. British Medical Journal 320, 305 309.
66. Talbot J. Stephens M.D.B 2004) Clinical trials: collection of safety data and establishing the adverse drug reaction profile. In Stephens' Detection of New Adverse Drug Reactions (J. Talbot P. Walker P. eds), pp. 167 242. Wiley, Chichester.
67. Taylor D., Paton C. Kerwin R 2007) The Maudsley Prescribing Guidelines, 9th edn. Informa Healthcare, London.
68. Thacker S. Jones R. (1997) Neuroleptic prescribing to the community elderly in Nottingham. International Journal of Geriatric Psychiatry 12 (8 833 837.
69. Tierney W. (2003) Adverse outpatient drug events - a problem and opportunity. New England Journal of Medicine 348 (16 1587 1589.
70. Uitenbroek D.G 1997) SISA-Binomial (SISA Simple Interactive Statistical Analysis) [www document]. Available at http://www.quantitativeskills.com/sisa/, accessed on 26 October 2008.
71. WAG (Welsh Assembly Government) (2005a) Raising the Standard: the Revised Adult Mental Health NSF and an Action Plan for Wales. Welah Assembly Government, Cardiff.
72. WAG (2005b) Policy Implementation Guidance on the development of Crisis Resolution/Home Treatment (CR/HT) services in Wales. Welsh Assembly Government, Cardiff.
73. WAG (Welsh Assembly Government) (2006) Mid Year Population Estimate. Welsh Assembly Government, Cardiff. Available at http://www.statswales.wales. gov.UK/TableViewer/tableView.aspx?ReportId=3122, accessed on 23 October 2008.
74. Walker H. MacAulay K. (2005) Assessment of the side effects of antipsychotic medication. Nursing Standard 19 (40 41 46.
75. Weiden PJ., Aquila R., Emanuel M. Zygmunt A. (1998) Long term considerations after switching antipsychotics. Journal of Clinical Psychiatry 59 (Suppl. 19 36 49.
76. Wernicke J., Faries D., Milton D. Weyrauch K. (2006) Detecting treatment emergent adverse events in clinical trials. A comparison of spontaneously reported and solicited collection methods. Drug safety 28 (11 1057 1063.